Sagimet Biosciences Inc.

10/11/2024 | Press release | Distributed by Public on 10/11/2024 05:33

Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE 2 Clinical Trial of Denifanstat in Biopsy Confirmed F2/F3 MASH in The Lancet Gastroenterology &[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.